Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g 4 Regulatory News (MAV4)

Share Price Information for Maven I&g 4 (MAV4)

Share Price is delayed by 15 minutes
Get Live Data
50.00    0.00 (0.00%)
Bid:
49.00
Ask:
51.00
Spread: 2.00 (4.082%)
Market Cap: £83.71m
MAV4 Live PriceLast checked at - London Stock Exchange

Intraday Maven I&g 4 Share Chart

Interim Management Statement - Amendment

16 Nov 2009 12:04

RNS Number : 5579C
Aberdeen Grwth Opp VCT2 PLC
16 November 2009
 



Aberdeen Growth Opportunities VCT PLC 

Correction to Interim Management Statement 

This is a correction to the previous announcement of the Interim Management Statement, which contained an error in the last line. The corrected Interim Management Statement is set out below:

1. Net Asset Value

Ordinary share net asset value (NAV) of 89.5p at 30 September 2009

S Ordinary share net asset value (NAV) of 94.2p at 30 September 2009 

The NAVs shown above are unaudited and reflect the closing bid prices of quoted securities at 30 September 2009. Unlisted companies are normally valued on a six-monthly basis and the NAVs include the Directors' valuations of unlisted investments as at 30 June 2009 adjusted for material developments within the portfolios since that date.  

2. Investments and disposals

During the quarter ended 30 September 2009the Ordinary share portfolio invested £37,000 in Adler and Allan. During the same period, disposals generated aggregate proceeds of £473,613 against cost of £457,820.

The S share portfolio invested £19,000 in the same company and during the same period, generated aggregate disposals proceeds of £165,324 against cost of £145,250.

There were no other material transactions during the period under review. 

3. Recent developments 

No further investments have been made between 30 September 2009 and the date of this statement. Since 30 September 2009, the investment in Cyclotech has been sold, realising proceeds of £688,000 and £275,000 for the Ordinary and S ordinary portfolios, compared with costs of £248,661 and £99,464 respectively. During that period, further disposals generated proceeds of £18,331 for each of the Ordinary share portfolio and the S share portfolio against similar costs.

The Board is not aware of any other events or transactions that have taken place between 30 September 2009 and the date of publication of this statement and which would have had a material impact on the financial position of the Company. 

Issued on behalf of the Board

Maven Capital Partners UK LLP, Secretary

16 November 2009

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBFBBTMMBBBLL
Date   Source Headline
19th Jul 201712:20 pmRNSStatement re Intended Offers for Subscription
19th Jul 201712:20 pmRNSStatement re Intended Offers for Subscription
15th Jun 20174:00 pmRNSDividend Declaration
12th Jun 20174:24 pmRNSTransaction in Own Shares
17th May 20172:33 pmRNSNet Asset Value and Final Dividend
17th May 20172:25 pmRNSResult of AGM
7th Apr 20173:45 pmRNSAnnual Financial Report
2nd Mar 20173:11 pmRNSTransaction in Own Shares
28th Feb 20172:40 pmRNSNet Asset Value and Final Dividend
20th Dec 20164:51 pmRNSTransaction in Own Shares
10th Nov 201611:05 amRNSNet Asset Value(s)
23rd Sep 20165:10 pmRNSTransaction in Own Shares
20th Sep 20164:56 pmRNSTransaction in Own Shares
26th Aug 20164:07 pmRNSHalf-year Report
17th Aug 20162:12 pmRNSNet Asset Value(s)
24th May 20163:06 pmRNSTransaction in Own Shares
27th Apr 20161:50 pmRNSNet Asset Value(s) - Replacement
27th Apr 201612:58 pmRNSResult of AGM
27th Apr 201612:55 pmRNSNet Asset Value(s)
30th Mar 20165:29 pmRNSAnnual Financial Report
22nd Mar 20162:44 pmRNSTransaction in Own Shares
10th Mar 20164:55 pmRNSTransaction in Own Shares
8th Mar 20164:37 pmRNSTransaction in Own Shares
7th Mar 20164:33 pmRNSTransaction in Own Shares
2nd Mar 20164:09 pmRNSNet Asset Value and Proposed Final Dividend
9th Dec 20154:15 pmRNSPortfolio Update and Unaudited Net Asset Value
27th Nov 20154:36 pmRNSTransaction in Own Shares
17th Nov 201512:59 pmRNSTransaction in Own Shares
16th Nov 20152:17 pmRNSTransaction in Own Shares
12th Nov 201510:34 amRNSNet Asset Value(s)
4th Sep 20153:20 pmRNSTransaction in Own Shares
28th Aug 201512:20 pmRNSHalf Yearly Report
24th Aug 20153:39 pmRNSStatement re Dividend Investment Scheme
20th Aug 20154:50 pmRNSTransaction in Own Shares
20th Aug 201511:47 amRNSStatement re Net Asset Value and Dividend
23rd Jun 20154:51 pmRNSTransaction in Own Shares
12th Jun 201510:02 amRNSIssue of Equity
5th Jun 20153:18 pmRNSNet Asset Value(s)
27th May 20159:34 amRNSTransaction in Own Shares
15th May 20152:17 pmRNSTransaction in Own Shares
14th May 201512:38 pmRNSTransaction in Own Shares
13th May 20153:21 pmRNSTransaction in Own Shares
12th May 20154:39 pmRNSNet Asset Value(s)
29th Apr 20152:13 pmRNSDirectorate Change
29th Apr 20152:13 pmRNSResult of AGM
13th Apr 20153:12 pmRNSIssue of Equity
30th Mar 20152:26 pmRNSTransaction in Own Shares
26th Mar 201512:52 pmRNSTransaction in Own Shares
25th Mar 20152:38 pmRNSTransaction in Own Shares
24th Mar 20154:37 pmRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.